-
[Good News] A subsidiary of Cell Valley Group has successfully obtained China's first FDA DMF filing for a retroviral vector and become the world's first company to receive approval for a Trop2-IL15 vChina, Shenzhen, December 2025) — Guangdong JUNJO Pharma Co., Ltd., a wholly-owned subsidiary of Cell Valley Group, officially announced that its GMP-grade GALV...12-09 -
Exclusive research data from Cell Valley reveals that NK exosomes demonstrate superior skin repair potential, positioning them as a promising anti-aging solution for future skin rejuvenation.While the NK cell exosome product became the first in the industry to obtain FDA DMF approval, Shenzhen Cell Valley simultaneously conducted comprehensive safet...12-09 -
[Good News] Shenzhen Cell Valley becomes the world's first company to obtain the Drug Master File (DMF) filing for NK cell-derived exosomes from the U.S. FDA(China Shenzhen, December 2025) — Shenzhen Cell Valley Biomedical Co., Ltd. officially announced that the NK cell-derived exosomes submitted by the company have...12-09 -
Shenzhen Cell Valley and Shenzhen Research Institute of Central South University Forge Industry-University-Research Partnership to Advance Biomedical Innovation and TranslationRecently, the Central South University Greater Bay Area Biomedical Achievement Matchmaking Conference & the 5th Health Innovation and Translation Forum was gran...12-01 -
A Strategic Partnership Forged: Shenzhen Cell Valley and Hefei Innovation Institute Embark on a New JourneyOn September 9, 2025, a delegation from Shenzhen Cell Valley, led by its Chairman Professor Shi Yuanyuan, and including Marketing Director Sun Rui and Project M...12-01 -
A delegation from the International Cooperation Center of the National Development and Reform Commission visited Deep Harbour Cell Valley for an inspection.To thoroughly implement the strategic deployment of expanding high-level opening-up as outlined in the Third Plenary Session of the 20th CPC Central Committee, ...12-01

